✦ LIBER ✦

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

✍ Scribed by Hartmann, J T; Oechsle, K; Quietzsch, D; Wein, A; Hofheinz, R D; Honecker, F; Nehls, O; Köhne, C-H; Käfer, G; Kanz, L

Book ID: 109997836
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 103 KB
Volume: 89
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601412

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

✍ Hofheinz, R-D; Willer, A; Weisser, A; Gnad, U; Saussele, S; Kreil, S; Hartmann, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

High dose folinic acid/etoposide/5-fluor

High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk

✍ H. Wilke; P. Preusser; U. Fink; W. Achterrath; L. Lenaz; M. Stahl; C. Schober; H 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 389 KB

Thirty-four consecutive patients with measurable advanced gastric cancer were treated in a disease oriented Phase II study with high-dose folinic acid (HDFA) 300 mg/m2 10 min. inf., followed immediately by etoposide 120 mg/m2 50 min. inf., followed immediately by 5-fluorouracil (5-FU) 500 mg/m2 10 m

Plasma and salivary pharmacokinetics of

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

✍ J.M Joulia; F Pinguet; M Ychou; J Duffour; C Astre; F Bressolle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB

A phase I, II study of high-dose 5-fluor

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies

✍ Bach Ardalan; Kasi S. Sridhar; Pasquale Benedetto; Stephen Richman; Stuart Waldm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 3 views

360 Phase I/II study with paclitaxel in

360 Phase I/II study with paclitaxel in combination with weekly high dose 5-FU/Folinic acid in the treatment of metastatic breast cancer

✍ U. Klaassen; H. Wilke; D. Strumberg; C. Philippou Pari; A. Harstrick; W. Eberhar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB